Maker of CPAP alternative to go public

Tuesday, April 10, 2018

MINNEAPOLIS – Inspire Medical Systems, the maker of FDA-approved neurostimulation technology that provides treatment for moderate to severe OSA, has filed paperwork for an initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Inspire has applied to list its common stock on the New York Stock Exchange under the ticker symbol “INSP.” BofA Merrill Lynch and Goldman Sachs & Co. LLC are serving as join lead book-running managers for the proposed offering. Guggenheim Securities, Stifel, and Wells Fargo Securities are acting as co-managers. In 2016, Inspire Medical Systems accumulated $37.5 million in venture funding to increase sales of its pacemaker-sized, implantable device.